Milestone Pharmaceuticals Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
1.80 |
4.34 |
17.35 |
55.05 |
154.35 |
231.35 |
| Przychód Δ r/r |
0.00% |
141.06% |
299.86% |
217.29% |
180.38% |
49.89% |
| Przychód (min) |
0.34 |
1.85 |
2.40 |
10.27 |
28.80 |
43.16 |
| Przychód (max) |
4.20 |
6.20 |
43.70 |
128.58 |
360.52 |
540.37 |
| EBITDA (średnia) |
-0.36 |
-0.87 |
-3.47 |
-11.01 |
-30.87 |
-46.27 |
| EBIT (średnia) |
-0.36 |
-0.87 |
-3.47 |
-11.01 |
-30.87 |
-46.27 |
| EBIT % |
-20.00% |
-20.00% |
-20.00% |
-20.00% |
-20.00% |
-20.00% |
| Zysk netto (średni) |
-39.07 |
-49.92 |
-49.98 |
-33.59 |
0.93 |
31.42 |
| Zysk netto % |
-2170.46% |
-1150.59% |
-288.04% |
-61.02% |
0.60% |
13.58% |
| EPS (średnia) |
-0.63 |
-0.80 |
-0.80 |
-0.54 |
0.01 |
0.51 |
| Liczba analityków (Przychody) |
2 |
3 |
3 |
1 |
1 |
2 |
| Liczba analityków (EPS) |
3 |
3 |
3 |
1 |
1 |
1 |
| symbol |
MIST |
MIST |
MIST |
MIST |
MIST |
MIST |